Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport.
about
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryVesicular monoamine transporter 2: role as a novel target for drug developmentDirected evolution reveals hidden properties of VMAT, a neurotransmitter transporterDesign, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2.Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice.Structural conservation in the major facilitator superfamily as revealed by comparative modeling.Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?
P2860
Q24601233-7FC523BF-E795-4CFB-8B86-C56E5582F579Q24647764-79173F7F-2C5C-4DA7-9A02-2CC7404438A0Q28573346-8D510B9A-D296-4FC9-9371-D163520DCF37Q33738102-34100628-1B56-46D0-B3B9-13CFE0432214Q33854736-A55B6F69-9674-4155-AFC1-F2B6F4668427Q34042123-59B023D0-9C92-471F-A588-E4152BB97FCDQ35676678-F60B1AD3-5DEC-4BA6-A03F-230C8E330398Q35988085-156E045D-87F4-44EE-8AA8-AA0E41F77772Q36519313-5605EF38-9F1B-46A4-B7DF-B3F152B76C2EQ37451183-98336FDE-FAA7-49C3-936D-CF4ED4B38B49Q37589110-6E9B2CE2-9DD5-4661-8AC1-A7503F428923Q38134724-BF4FA7D6-7801-4348-8E57-C6EBE994376A
P2860
Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2) cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Mutagenesis and derivatization ...... nding and substrate transport.
@en
Mutagenesis and derivatization of human vesicle monoamine transporter 2
@nl
type
label
Mutagenesis and derivatization ...... nding and substrate transport.
@en
Mutagenesis and derivatization of human vesicle monoamine transporter 2
@nl
prefLabel
Mutagenesis and derivatization ...... nding and substrate transport.
@en
Mutagenesis and derivatization of human vesicle monoamine transporter 2
@nl
P2860
P356
P1476
Mutagenesis and derivatization ...... nding and substrate transport.
@en
P2093
P2860
P304
27304-27315
P356
10.1074/JBC.M103947200
P407
P577
2001-05-24T00:00:00Z